Axim Biotechnologies Inc (AXIM)

[Tiresias]

One use different from direct consumer acceptance would be in long term care facilities or hospitals to allow staff to determine the risk to the patient should there be an outbreak in a home (long term care residential) or hospital ward who have been provided the third, or booster jab. This would allow for selective placement into isolated areas where contact among staff/patients whose antibodies (the patients) are not as prevalent as others who receive the jab, lowering the risk of infection by knowing upfront the potential for transmission among the more poorly protected patients. This could go a long way to preventing further transmission and reduce the risk to insurers who might then cover the cost of the test and hopefully avoid a payout upon death of the patient, or long term care costs. At home testing is fine and well but studies have shown in other areas the inability to properly perform the test makes a negative/positive result less reliable.